Medications
Levofloxacin (Levaquin and others)
A fluoroquinolone antibiotic used to treat bacterial infections, including pneumonia, sinus infections, urinary tract infections, and prostate infections.
How Medicare covers it
Part D (tablets, oral liquid, and eye drops used at home). Part A during a covered inpatient stay. A clinician-administered intravenous form also has a Part B basis (see Part B status).
| Coverage details | |
|---|---|
| Part B status | CMS Part B Spending by Drug HCPCS file carries levofloxacin J1956 (Injection, levofloxacin, 250 mg) — the CMS basis for a clinician-administered Part B path. The usual at-home tablet path is Part D. |
| Medicare Advantage | Most Medicare Advantage plans that include drug coverage (MAPD plans) use the same formulary-and-tier system; the plan's own drug list decides coverage and copay — check the plan's formulary. |
| Medicare Supplement (Medigap) | Medicare Supplement (Medigap) plans sold today do not include prescription drug coverage; drug coverage comes from Part D or an MAPD plan. |
What it treats
Levofloxacin is a fluoroquinolone antibiotic for adults with bacterial infections, including hospital-acquired and community-acquired pneumonia, complicated and uncomplicated skin and skin-structure infections, chronic bacterial prostatitis, complicated and uncomplicated urinary tract infections, acute kidney infection (pyelonephritis), acute bacterial worsening of chronic bronchitis, and acute bacterial sinusitis. It is also used for inhalational anthrax after exposure and for plague, in adults and children where indicated. It works only against bacteria and should be used only for infections proven or strongly suspected to be bacterial.
What it is for, in depth
Levofloxacin is a fluoroquinolone antibiotic for adults with bacterial infections. It treats hospital-acquired and community-acquired pneumonia, complicated and uncomplicated skin infections, long-term bacterial prostate infection, and complicated and uncomplicated urinary tract infections, including kidney infection. It also treats a sudden bacterial worsening of chronic bronchitis and acute bacterial sinus infections. It is also used for inhalational anthrax after exposure and for plague, in adults and in children where the label allows it. It works only against bacteria, by blocking the tools bacteria need to copy and repair their DNA, so the bacteria die instead of multiplying. It should be used only for infections proven or strongly suspected to be bacterial. It comes as tablets in 250 mg, 500 mg, and 750 mg, usually taken once a day, with the dose and number of days set by the type of infection.
How it works
It is a fluoroquinolone antibacterial. It kills bacteria by blocking the enzymes bacteria need to copy and repair their DNA (DNA gyrase and topoisomerase IV), so the bacteria die instead of multiplying.
How it is taken
Tablets (250 mg, 500 mg, and 750 mg) taken by mouth, usually once a day; the dose and number of days depend on the infection, and people with kidney problems need lower or less frequent doses. Take levofloxacin tablets at least 2 hours before or 2 hours after antacids, sucralfate, iron, zinc, or multivitamins, which block its absorption. Drink plenty of fluids while taking it.
Common side effects
Common side effects (1% or more of patients) include nausea, diarrhea, headache, dizziness, trouble sleeping (insomnia), constipation, abdominal pain, and vomiting. Nausea, vomiting, dizziness, and headache were the effects that most often led people to stop the drug in trials.
Serious warnings
Levofloxacin can cause disabling and potentially permanent nerve damage (peripheral neuropathy), tendon inflammation and tendon rupture, central nervous system effects including seizures, confusion, tremors, hallucinations, and worsening of myasthenia gravis. Other serious risks include liver injury, QT prolongation (a dangerous heart rhythm change), aortic aneurysm and dissection, severe diarrhea from C. difficile, blood sugar disturbances (both low and high blood sugar), severe allergic and skin reactions, and increased sun sensitivity. Stop the drug and get care at once for tendon pain or swelling, numbness or weakness, or a severe rash.
Boxed warning
WARNING: SERIOUS ADVERSE REACTIONS INCLUDING TENDINITIS, TENDON RUPTURE, PERIPHERAL NEUROPATHY, CENTRAL NERVOUS SYSTEM EFFECTS AND EXACERBATION OF MYASTHENIA GRAVIS. Fluoroquinolones, including levofloxacin, have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together: tendinitis and tendon rupture, peripheral neuropathy, and central nervous system effects. Stop levofloxacin at once and avoid fluoroquinolones if any of these occur. Fluoroquinolones may worsen muscle weakness in people with myasthenia gravis, so levofloxacin should be avoided in people with a known history of myasthenia gravis. Because fluoroquinolones have been associated with serious adverse reactions, levofloxacin is reserved for patients with no alternative treatment options for uncomplicated urinary tract infection, acute bacterial exacerbation of chronic bronchitis, and acute bacterial sinusitis.
Who should be careful
People with a history of tendon problems or tendon rupture, myasthenia gravis (avoid), epilepsy or other seizure or central nervous system disorders, QT prolongation or low potassium or magnesium, diabetes, kidney impairment (dose changes needed), and older adults, who have a higher risk of tendon rupture (higher still with corticosteroids) and QT prolongation. Children can develop joint and tendon (musculoskeletal) problems, so use in children is limited to the indications on the label.
Major interactions
Antacids with magnesium or aluminum, sucralfate, iron and other metal cations, didanosine, and multivitamins with zinc cut levofloxacin absorption — separate them by at least 2 hours. Warfarin's effect may increase, so prothrombin time/INR should be monitored and bleeding watched for. Diabetes medicines need careful blood-sugar monitoring because levofloxacin can raise or lower blood sugar. NSAIDs taken with a fluoroquinolone can raise the risk of central nervous system stimulation and seizures, and corticosteroids raise tendon-rupture risk.
Why it is in its tier
Levofloxacin is most often placed on Tier 1. It is listed by 100.0% of Part D plans in the data, and 49.39% of the plans that list it put it on Tier 1. Tier 1 is the lowest-cost tier, usually for preferred generic drugs, and the standard copay range on this tier is $0-$15. The drivers you can see in the data fit that place: levofloxacin is a generic antibiotic, not a brand-only drug, and its cost level is very low. The CMS dashboard puts average spending per beneficiary at $8.00 for 2024. That is a CMS program average, not a copay and not what you will pay at the pharmacy. Individual plans vary, so check your own plan for your exact cost.
Sources
- LEVOFLOXACIN TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] — DailyMed
- MedlinePlus — National Library of Medicine
- MedlinePlus — Levofloxacin
What official patient guides say
Levofloxacin is taken by mouth every 24 to 48 hours, trying to take each dose around the same time of day for as long as your doctor tells you. The tablet may be taken with or without food, but the liquid solution should be taken 1 hour before or 2 hours after eating, and you should drink plenty of water or other fluids while taking it. If you miss a dose, take it as soon as you remember up to 8 hours before the next dose; if less than 8 hours remain, wait for the next dose and do not double up. Store it tightly closed at room temperature, away from excess heat and moisture.
Source: MedlinePlus — Levofloxacin
Part D formulary coverage
| Formulary summary | |
|---|---|
| Most common tier | 1 |
| Plans listing this drug | 5495 |
| Total Part D plans | 5495 |
| Share of plans listing it | 100 |
| Formularies listing it | 286 |
| Tier | Plans |
|---|---|
| Tier 1 | 2714 plans · See the 2081 plans on this site at this tier |
| Tier 2 | 2696 plans · See the 1220 plans on this site at this tier |
| Tier 3 | 37 plans · See the 3 plans on this site at this tier |
| Tier 4 | 48 plans · See the 13 plans on this site at this tier |
Source: CMS Prescription Drug Plan Formulary, Pharmacy Network, and Pricing Information Files — Monthly file 2026-10-15 (plan year 2027), file 2027_20261008.zip (data.cms.gov dataset ed1496ea-23e7-41f1-9292-172fa842ccfb): basic drugs formulary file + plan information file, both dated 20261031 inside the zip; downloaded and aggregated 2026-10-30. Medication RxCUI sets resolved through the NLM RxNav (RxNorm) API.
What you pay
| With Medicare Part D | |
|---|---|
| Most common tier | Tier 1 |
| Typical copay | $0 — half of plans charge between $0 and $0 |
| Typical coinsurance | 25.0% of the price |
| Based on | 2552 plans that cover this drug · 2027 plan year |
Without insurance, the cash benchmark is $1.3322 per unit (LEVOFLOXACIN 25 MG/ML SOLUTION) — about $39.97 for 30 units. NADAC benchmark — the average price pharmacies pay (CMS, as of 2026-11-04). Pharmacy shelf prices vary.
A tier is not a price; what you pay depends on your plan, pharmacy, and benefit stage; Extra Help or Medicaid can lower it further.
Sources: CMS Plan Benefit Package + formulary data; CMS NADAC · Checked 2026-11-08
Coverage by plan and tier
Of the 5,495 Medicare drug plans we track for 2027, 5,495 list Levofloxacin (Levaquin and others) — 100% of plans. Most of those plans put it on Tier 1: 2,714 plans, 49.4% of the plans that list it. Other plans place it on Tier 2 (2,696 plans), Tier 4 (48 plans) or Tier 3 (37 plans). For example: Aetna Medicare Dual Extra (HMO D-SNP) puts it on Tier 2; Aetna Medicare Dual Extra Care (PPO D-SNP) puts it on Tier 2; Aetna Medicare Value Plus (PPO) puts it on Tier 2. You can compare these plans side by side on our Medicare Advantage hub. A tier is not a price. What you pay also depends on whether you have met your plan's deductible, whether the drug costs a flat copay or a share of the price, and whether you get Extra Help or Medicaid.
Read next
Part D spending averages (2024)
| Brand name | Generic name | Total claims 2024 | Total spending 2024 | Total beneficiaries 2024 | Rank by beneficiaries 2024 |
|---|---|---|---|---|---|
| Levofloxacin* | Levofloxacin | 2.49955e+06 | 1.49228e+07 | 1866045 | 67 |
Source: CMS Medicare Part D Spending by Drug (Drug Spending Dashboard), release RY26 P04 V10, data through 2024 (DSD_PTD_RY26_P04_V10_DY24_BGM.csv), downloaded 2026-10-30
Companies covering this drug
Part D and Medicare Advantage plan sponsors that list this drug on a formulary, 50 at a time.
Coverage and costs change. Drug lists (formularies), tiers, and copays can change during the year and differ by plan. Always check with your insurance company or plan directly to confirm what is covered and what you will pay.
Care and Living Guide is not connected with or endorsed by the U.S. government or the federal Medicare program. For official information visit Medicare.gov or call 1-800-MEDICARE.